Clinico-pathologic, immunohistochemical, and TUNEL study in early cardiac allograft failure

Cardiovascular Pathology

Volumn 9, Issue 3, 2000, Pages 153-159

  Panizo Santos, Angel ^a   Lozano, MaríaDolores ^a   Distefano, Salvatore ^a   Inogés, Susana ^a   Pardo, Javier ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA TUBULIN; DNA; FIBRONECTIN;

ADULT; APOPTOSIS; ARTICLE; AUTOPSY; CLINICAL ARTICLE; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DNA STRAND BREAKAGE; ENDOTHELIUM; FEMALE; GRAFT FAILURE; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE NECROSIS; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ISCHEMIC HEART DISEASE; MALE; NICK END LABELING; PRIORITY JOURNAL;

ADULT; APOPTOSIS; FEMALE; FIBRONECTINS; GRAFT REJECTION; HEART SEPTUM; HEART TRANSPLANTATION; HEART VENTRICLES; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU NICK-END LABELING; MALE; MIDDLE AGED; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; TRANSPLANTATION, HOMOLOGOUS; TUBULIN;

EID: 0033828188     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1054-8807(00)00039-9     Document Type: Article

References (28)

1. Costanzo-Nordin M.R., Heroux A.L., Radvany R.et al. Role of humoral immunity in acute cardiac allograft dysfunction. J Heart Lung Transplant. 12:1993;S143-S146.
2. Kriett J.M., Kaye M.P. The Registry of the International Society for Heart and Lung Transplantation. Eighth Official Report, 1991 J Heart Lung Transplant. 10:1991;491-498.
3. Davies M.J. Apoptosis in cardiovascular disease. Heart. 77:1997;498-501.
4. Haunstetter A., Izumo S. Apoptosis. Basic mechanisms and implications for cardiovascular disease Circ Res. 82:1998;1111-1129.
5. Díez J., Panizo A., Hernández M.et al. Cardiomyocyte apoptosis and cardiac angiotensin-converting enzyme in spontaneously hypertensive rats. Hypertension. 30:1997;1029-1034.
6. Hauptman P.J., Aranki S., Mudge G.H.et al. Early cardiac allograft failure after orthotopic heart transplantation. Am Heart J. 127:1994;179-186.
7. Gallo P., Agozzino L., Arbustini E.et al. Immediate causes of death in short-term surviving heart transplant recipients. Cardiovasc Pathol. 3:1994;173-181.
8. Jurmann M.J., Wahlers T., Coppola R.et al. Early graft failure after heart transplantation. management by extracorporeal circulatory assist and retransplantation J Heart Transplant. 8:1989;474-478.
9. Fyfe B., Loh E., Winters G.L.et al. Heart transplantation-associated perioperative ischemic myocardial injury. Morphological features and clinical significance Circulation. 93:1996;1133-1140.
10. Trieb K., Eberl T., Steger M.et al. Apoptosis is involved in endothelial cell damage during preservation and influenced by organ storage solutions. Transplant Proc. 29:1997;416-418.
11. Panizo A., Pardo F.J., Lozano M.D., de Alava E., Sola I., Idoate M.A. Ischemic injury in posttransplant endomyocardial biopsies. immunohistochemical study of fibronectin Transplant Proc. 31:1999;2550-2551.
12. Casscells W., Kimura H., Sanchez J.A.et al. Immunohistochemical study of fibronectin in experimental myocardial infarction. Am J Pathol. 137:1990;801-810.
13. Ratajska A., Campbell S.E. Fibronectin accumulation within cardiac myocytes in rats with elevated plasma angiotensin. Cardiovasc Pathol. 4:1995;57-67.
14. Hu B.J., Chen Y.C., Zhu J.Z. Immunohistochemical study of fibronectin for post mortem diagnosis of early myocardial infarction. Forensic Sci Int. 78:1996;209-217.
15. Labarrere C.A., Nelson D.R., Faulk W.P. Myocardial fibrin deposits in the first month after transplantation predict subsequent coronary artery disease and graft failure in cardiac allograft recipients. Am J Med. 105:1998;207-213.
16. Hein S., Scheffold T., Schaper J. Ischemia induces early changes to cytoskeletal and contractile proteins in diseased human myocardium. J Thorac Cardiovasc Surg. 110:1995;89-98.
17. Iwai K., Hori M., Kitabatake A.et al. Disruption of microtubules as an early sign of irreversible ischemic injury. immunohistochemical study of in situ canine hearts Circ Res. 67:1990;694-706.
18. Itescu S., Tung T.C., Burke E.M., Weinberg A., Moazami N., Artrip J.H., Suciu-Foca N., Rose E.A., Oz M.C., Michler R.E. Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation. Circulation. 98:1998;786-793.
19. Trento A., Hardest R.L., Griffith B.P.et al. Role of the antibody to vascular endothelial cells in hyperacute rejection in patients undergoing cardiac transplantation. J Thorac Cardiovasc Surg. 95:1988;37-41.
20. Wang C.Y., Naka Y., Liao H., Oz M.C., Springer T.A., Gutierrez-Ramos J.C., Pinsky D.J. Cardiac graft intercellular adhesion molecule-1 (ICAM-1) and interleukin-1 expression mediate primary isograft failure and induction of ICAM-1 in organs remote from the site of transplantation. Circ Res. 82:1998;762-772.
21. Labat-Moleur F., Guillermet C., Lorimier P.et al. TUNEL apoptotic cell detection in tissue sections. critical evaluation and improvement J Histochem Cytochem. 46:1998;327-334.
22. Szabolcs M., Michler R.E., Yang X.et al. Apoptosis of cardiac myocytes during cardiac allograft rejection. Relation to induction of nitric oxide synthase. Circulation. 94:1996;1665-1673.
23. White W.L., Zhang Y.L., Shelby J.et al. Myocardial apoptosis in a heterotopic murine heart transplantation model of chronic rejection and graft vasculopathy. J Heart Lung Transplant. 16:1997;250-255.
24. Shaddy R.E. Apoptosis in heart transplantation. Coron Artery Dis. 10:1997;617-620.
25. Gottliberg R.A., Burlesson K.O., Kloner R.A., Babior B.M., Engler R.L. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest. 94:1994;1621-1628.
26. Takemura G., Ohno M., Hayakawa Y.et al. Role of apoptosis in the disappearance of infiltrated and proliferated interstitial cells after myocardial infarction. Circ Res. 82:1998;1130-1138.
27. Jeroudi M.O., Hartley C.J., Bolli R. Myocardial reperfusion injury. role of oxygen radicals and potential therapy with antioxidants Am J Cardiol. 73:1994;2B-7B.
28. Vakeva A.P., Agah A., Rollins S.A., Matis L.A., Li L., Stahl G.L. Myocardial infarction and apoptosis after myocardial ischemia and reperfusion. Role of the terminal complement components and inhibition by anti-C5 therapy. Circulation. 97:1998;2259-2267.